RNS Number : 7777X
  Tepnel Life Sciences PLC
  30 June 2008
   

    Tepnel Life Sciences Plc ("the Company")

    Holding in Company


    The Company was informed on the 27 June 2008, that Gartmore Investment Ltd has a notifiable interest of 11,873,355 ordinary shares in
the Company, representing approximately 5.158% of the issued share capital of the Company.




    For further information:

    Tepnel Life Sciences plc
    Ben Matzilevich, Chief Executive Officer
    Michael Slater, Group Finance Director
    Tel: 0161 946 2200

    Capital MS&L
    Mary Clark or Joanna Whineray
    Tel: +44 20 7307 5330

    Seymour Pierce Limited
    Mark Percy
    Tel: +44 20 7107 8000


    Notes to Editors:

    About Tepnel Life Sciences plc
    Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences products and services Group with two divisions, Molecular
Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France with over
200 employees. Tepnel provides test kits, reagents and services to two highly synergistic markets, these being Molecular Diagnostics and
Biomedical Research. The Company's strategy has been to identify high growth niche opportunities within these multi-billion pound markets.
Tepnel focuses on these niche operations with internally developed products, patents, expertise and know-how as well as strategic
acquisitions, to develop a leadership position within these 


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLUBOVRWBRNUAR

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Ted Baker Charts.
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Ted Baker Charts.